Invasive lobular carcinoma of the breast presenting successively with colonic and gastric metastases

International Journal of Clinical Practice

Volumn 56, Issue 8, 2002, Pages 623-625

  Basu, S ^a   Last, A ^a   Shinkfield, M ^a  

^a NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTHRACYCLINE; ANTIBIOTIC AGENT; DOCETAXEL; DOXORUBICIN; TAMOXIFEN;

AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CASE REPORT; COLON CANCER; DISEASE COURSE; FEMALE; HUMAN; MASTECTOMY; PRIORITY JOURNAL; SIDE EFFECT; STOMACH CANCER; VISCERAL METASTASIS;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; COLONIC NEOPLASMS; DOXORUBICIN; ENDOSCOPY; FEMALE; HUMANS; NITRILES; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TRIAZOLES;

EID: 0036775764     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cancer Research Campaign. Breast cancer. Factsheet, 1997.
2. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology 1979; 3: 467-488.
3. Dixon JM, Anderson TJ, Page DL et al. Infiltrating lobular carcinoma of the breast. Histopathology 1982; 6: 149-161.
4. Hayes DF, Kaplan W. Evaluation of patients after primary therapy. In: Harris JR, Lippman ME, Morrow M et al, Eds. Diseases of the breast. Philadelphia: Lippincott-Raven, 1996; 629-647.
5. Cifuentes N, Pickren JW. Metastases from carcinoma of mammary gland: an autopsy study. J Surg Oncol 1979; 11: 193-205.
6. Lee YTN. breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 1983; 23: 175-180.
7. du Toit RS, Locker AP, Ellis IO et al. An evalution of differences in prognosis, recurrence patterns and receptor status between lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 1991; 17: 251-257.
8. Jain, S, Fisher C, Smith P et al. Patterns of metastatic breast cancer in relation to histological type. Eur J Cancer 1993; 29A: 2155-2157.
9. Borst MJ, Ingold JA. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 1993; 114: 637-642.
10. Sastre-Garau X, Jouve M, Asselain B et al. Infiltrating lobular carcinoma of the breast. Cancer 1996; 77: 113-120.
11. Harris M, Howell A, Chrissohou M et al. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984; 50: 23-30.
12. Lamovec J, Bracko M. Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study. J Surg Oncol 1991; 48: 28-33.
13. Davis H Jr, Murray RK, Korbitz BC. Breast carcinoma metastatic to the stomach: report of a case in a male and review of an autopsy series. Am J Dig Dis 1968; 13: 868-873.
14. Yosida Y. Metastases and primary neoplasms of the stomach in patients with breast cancer. Am J Surg 1973; 125: 738-743.
15. Taal BG, den Hartog Jager FCA, Steinmetz R, Peterse H. The spectrum of gastrointestinal metastases of breast carcinoma: 1. Stomach. Gastrointest Endosc 1992; 38: 130-135.
16. Schartz ES, Klimstra DS, Turnbull ADM. Metastatic breast cancer masquerading as gastrointestinal primary. Am J Gastroenterol 1998; 93(1): 111-114.
17. Graham WP, Goldman L. Gastro-intestinal metastases from carcinoma of the breast. Ann Surg 1964; 159: 477-480.
18. Choi SH, Sheekan FR, Pickren JW. Metastatic involvement of the stomach by breast cancer. Cancer 1964; 17: 791-797.
19. Claviens PA, Laffer U, Torhost J, Harder F. Gastro-intestinal metastases as first clinical manifestation of the dissemination of a breast cancer. Eur J Surg Oncol 1990; 16: 121-126.
20. Cormier WJ, Gaffey TA, Welch JM et al. Linitis plastica caused by metastatic lobular carcinoma of the breast. Mayo Clin Proc 1980; 55: 747-753.
21. Taal BG, den Hartog Jager FCA, Steinmetz R, Peterse H. The spectrum of gastro-intestinal metastases of breast carcinoma: II The colon and rectum. Gastrointest Endosc 1992; 38: 136-141.
22. Mouridsen HT. Systemic therapy of advanced breast cancer. Drugs 1992; 44: 17-28.
23. O'Brien MER, Leonard RC, Barrett-Lee PJ et al. Docetaxel in the community setting: an analysis of 377 breast cancer patients treated with docetaxel (Taxotere) in the UK. Ann Oncol 1999; 10: 205-210.
24. Leonard RCF, Rodger A, Dixon JM. ABC of breast disease: metastatic breast cancer. BMJ 1994; 309: 1501-1504.
25. Henderson IC. Principles in the management of metastatic disease, chemotherapy for metastatic disease. In Harris JR, Hellman S, Henderson IC et al, Eds. Breast diseases. Philadelphia: Lippincott, 1991; 604-665.
26. Pronk LC, Storer G, Verweij J. Docetaxel (Taxotere): Single-agent activity, development of combination treatment and reducing side-effects. Cancer Treatment Rev 1995; 21: 463-478.
27. Van Oosterom AT. Docetaxel (Taxotere): an effective agent in the management of second-line breast cancer. Semin Oncol 1995; 22: 22-28.
28. McGuire WL. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol 1978; 5: 428-443.
29. Kuss JT, Muss HB, Hoen H, Case LD. Tamoxifen as initial endocrine therapy for metastatic breast cancer: long term follow-up of two Piedmont Oncology Association (POA) trials. Breast Cancer Res Treat 1997; 42: 265-274.
30. Buzdar A, Jonat W, Howell A et al. Anastozole, a potent and selective aromatase inhibitor, versus megesterol acetate in post-menopausal women with advance breast cancer; results of overview analysis of two phase III trials. J Clin Oncol 1996; 14(7): 2000-2011.
31. Buzdar A, Jonat W, Howell A et al. Anastrozole versus megesterol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase II1 trials. Cancer 1998; 83(6): 1142-1152.
32. Sedlaced SM. An overview of megesterol acetate for the treatment of advanced breast cancer. Semin Oncol 1988; 15(suppl 1): 3.
33. Ferri LE, Onerheim R, Emond C. Linitis plastica as the first indication of metastatic lobular carcinoma of the breast: case report and literature review. Can J Surg 1999; 42(6): 466-469.
34. Miles DW, Twelves, Eggleton SPH et al. Quality of life effects of therapy in 184 patients with anthracycline-pretreated metastatic breast cancer. Ann Oncol 1998; 9(suppl 1) 4.